ReviewChirurgie (Heidelberg, Germany)2026
[Anorectal functional disorders following organ-preserving treatment and resection of rectal cancer].
Review in Chirurgie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anorectal functional disorders following curative treatment for rectal cancer range from fecal incontinence to obstructed defecation and represent a symptom complex with tremendous impact on the quality of life in up to 70% of patients. Following resection, symptoms are defined as low anterior resection syndrome (LARS) and can be differentiated into minor LARS and major LARS. Independent factors predictive of LARS include total mesorectal excision, level of the anastomosis and neoadjuvant chemoradiotherapy. Therapeutic options include conservative management (dietary modification, stool regulation), pelvic floor rehabilitation and transanal irrigation. Sacral neuromodulation has been shown to be effective for major LARS. In general, multidisciplinary teams providing professional management according to patient-reported outcome measurements are mandatory. Based on the prevalence of anorectal functional disorders after resection and organ preservation, the description of symptoms restricted to LARS no longer seems appropriate and a new consensus-based definition should be developed.
Indexed as
Identifiers
41857346What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.